Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$55.90 USD

55.90
23,942,853

+0.75 (1.36%)

Updated May 3, 2024 04:00 PM ET

After-Market: $55.93 +0.03 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 8% (233 out of 252)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Company News for May 2, 2024

Companies In The News Are: CVS, PFE, PPL, ADP.

CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up

CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.

CVS Health (CVS) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CVS Health (CVS) Misses Q1 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of -22.49% and 0.86%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note

CVS Health (CVS) closed at $67.18 in the latest trading session, marking a -0.22% move from the prior day.

Gear Up for CVS Health (CVS) Q1 Earnings: Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Why CVS Health (CVS) Dipped More Than Broader Market Today

The latest trading day saw CVS Health (CVS) settling at $67.33, representing a -0.65% change from its previous close.

Earnings Preview: CVS Health (CVS) Q1 Earnings Expected to Decline

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.

CVS Health (CVS) Rises As Market Takes a Dip: Key Facts

CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

The strength of a diversified enterprise, along with robust operational execution, is expected to be reflected in CVS Health's (CVS) first-quarter 2024 results.

CVS Health (CVS) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, CVS Health (CVS) stood at $68.64, denoting a -1.58% change from the preceding trading day.

CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note

CVS Health (CVS) closed at $73.36 in the latest trading session, marking a -1.45% move from the prior day.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Fastenal (FAST) to Post Q1 Earnings: What's in the Cards?

Fastenal's (FAST) Q1 results are likely to reflect manufacturing growth, albeit at a slow pace, with a strong digital strategy and a balanced onsite/offsite mix. Yet, slowing industrial markets are a concern.

CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?

Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Herbalife and Amazon

CVS Health, Walgreens Boots Alliance, Herbalife and Amazon have been highlighted in this Industry Outlook article.

CVS Health (CVS) Outperforms Broader Market: What You Need to Know

CVS Health (CVS) closed the most recent trading day at $74.60, moving +1.06% from the previous trading session.

Urmimala Biswas headshot

2 Retail Pharmacy Stocks to Watch and One to Avoid Amid Industry Headwinds

Zacks Retail-Pharmacies and Drug Stores industry players like CVS and WBA are likely to gain despite reimbursement challenges that are hurting the overall health industry. HLF might face the wrath of economic challenges.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Kaibalya Pravo Dey headshot

Health Insurance Stocks Drop: Insights Into the Late Monday Fall

Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.